Parotid neoplasms: analysis of 600 patients attended at a single institution.

Parotid neoplasms : analysis of 600 patients attended at a single institution Summary

ACINIC CELL CARCINOMA OF THE PAROTID GLAND: A 15-YEAR REVIEW LIMITED TO A SINGLE SURGEON AT A SINGLE INSTITUTION Acinic cell carcinoma of the parotid gland: A 15-year review limited to a single surgeon at a single institution

The course of acinic cell carcinoma of the parotid gland following surgical and nonsurgical interventions is variable. The objective of this study was to report our experience in treating this disease and to evaluate the factors that might be involved in the treatment of the tumor and the prognosis of the patient. To limit the contributory variables that are usually found in most studies, we in...

Serous Otitis Media in Pre-School Children

Introduction: Salivary gland tumors are relatively rare and constitute 3-4% of all head and neck neoplasms. The majority (70%) of salivary gland tumors arise in the parotid gland. Recommended treatment for a parotid mass is surgical excision with a surrounding cuff of normal tissue to prevent recurrence. Materials and Methods: This is a retrospective study of 300 patients who were operated b...

Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas.

OBJECTIVE To analyze risk factors for neck metastases in patients with parotid carcinomas. DESIGN Cohort of patients followed up from 1 to 366.2 months at a single institution. SETTING Referral center, private or institutional practice, hospitalized care. PATIENTS A total of 145 patients with parotid carcinomas with complete clinical and pathological information. The histological diagnosi...

Survival Outcomes of Patients Treated with Hypofractionated Stereotactic Body Radiation Therapy for Parotid Gland Tumors: a Retrospective Analysis

BACKGROUND to review a single-institution experience with the management of parotid malignancies treated by fractionated stereotactic body radiosurgery (SBRT). FINDINGS Between 2003 and 2011, 13 patients diagnosed with parotid malignancies were treated with adjuvant or definitive SBRT to a median dose of 33 Gy (range 25-40 Gy). There were 11 male and two female patients with a median age of 8...